bunazosin + valsartan

**bunazosin + valsartan** is a combination therapy comprised of an α1-adrenergic receptor antagonist (bunazosin) and an angiotensin II receptor blocker (valsartan). Bunazosin works by blocking α1-adrenoceptors in vascular smooth muscle, leading to vasodilation and subsequent reduction in blood pressure. Valsartan selectively inhibits the angiotensin II type 1 (AT1) receptor, preventing the vasoconstrictive and aldosterone-secreting effects of angiotensin II. This combination is used to treat essential hypertension, particularly for patients whose blood pressure is inadequately controlled by valsartan monotherapy. Clinical evidence supports its use as add-on therapy, showing that it provides meaningful reductions in both systolic and diastolic blood pressures, especially in patients with stage 2 hypertension. The combination is generally well-tolerated, with side effects including dizziness, headache, and palpitations, most of which are mild in intensity[1][3].